Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: Therapeutic efficacy largely depends on radiosensitivity

Annals of Nuclear Medicine

Volumn 23, Issue 5, 2009, Pages 479-485

  Hanaoka, Hirofumi ^a   Katagiri, Toyomasa ^b   Fukukawa, Chikako ^b   Yoshioka, Hiroki ^a   Yamamoto, Shinji ^a   Iida, Yasuhiko ^a   Higuchi, Tetsuya ^a   Oriuchi, Noboru ^a   Paudyal, Bishnuhari ^a   Paudyal, Pramila ^a   Nakamura, Yusuke ^b   Endo, Keigo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Apoptosis; FZD10; Radioimmunotherapy (RIT); Radiosensitivity

Indexed keywords

CELL SURFACE PROTEIN; MONOCLONAL ANTIBODY I 125; MONOCLONAL ANTIBODY IN 111; MONOCLONAL ANTIBODY Y 90; PROTEIN FZD10; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOTHERAPY; RADIOSENSITIVITY; SYNOVIAL SARCOMA;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL SURVIVAL; FRIZZLED RECEPTORS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NEOPLASMS; RADIATION TOLERANCE; RADIOIMMUNOTHERAPY; RECEPTORS, G-PROTEIN-COUPLED; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

EID: 70349575503     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-009-0265-1     Document Type: Article

References (28)

1. TE Witzig A Molina LI Gordon C Emmanouilides RJ Schilder IW Flinn, et al. 2007 Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan Cancer 109 1804 1810 17380530 10.1002/cncr.22617 1:CAS:528:DC%2BD2sXlsF2nurw%3D (Pubitemid 46668544)
2. RI Fisher MS Kaminski RL Wahl SJ Knox AD Zelenetz JM Vose, et al. 2005 Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lymphomas J Clin Oncol 23 7565 7573 16186600 10.1200/JCO.2004.00. 9217 1:CAS:528:DC%2BD2MXht1Wrsr3N (Pubitemid 46291820)
3. MJ Verhaar-Langereis BA Zonnenberg JM de Klerk GH Blijham 2000 Radioimmunodiagnosis and therapy Cancer Treat Rev 26 3 10 10660488 10.1053/ctrv.1999.0146 1:STN:280:DC%2BD3c7islyjug%3D%3D (Pubitemid 30102797)
4. DM Goldenberg 2003 Advancing role of radiolabeled antibodies in the therapy of cancer Cancer Immunol Immunother 52 281 296 12700944 1:CAS:528:DC%2BD3sXivFygsL8%3D
5. YS Jhanwar C Divgi 2005 Current status of therapy of solid tumors J Nucl Med 46 141S 150S 15653662
6. MJ Koppe EJ Postema F Aarts WJ Oyen RP Bleichrodt OC Boerman 2005 Antibody-guided radiation therapy of cancer Cancer Metastasis Rev 24 539 567 16408161 10.1007/s10555-005-6195-z 1:CAS:528:DC%2BD28XjsFKjsg%3D%3D (Pubitemid 43097000)
7. CA Boswell MW Brechbiel 2007 Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view Nucl Med Biol 34 757 778 17921028 10.1016/j.nucmedbio.2007.04.001 1:CAS:528:DC%2BD2sXhtFeiu77K (Pubitemid 47503817)
8. J Koike A Takagi T Miwa M Hirai M Terada M Katoh 1999 Molecular cloning of Frizzled-10, a novel member of the Frizzled gene family Biochem Biophys Res Commun 262 39 43 10448064 10.1006/bbrc.1999.1161 1:CAS:528:DyaK1MXltFShtbc%3D (Pubitemid 29412619)
9. S Nagayama T Katagiri T Tsunoda T Hosaka Y Nakashima N Araki, et al. 2002 Genome-wide analysis of gene expression in synovial sarcomas using a cDNA Microarray Cancer Res 62 5859 5866 12384549 1:CAS:528:DC%2BD38XotFykt7g%3D (Pubitemid 35204746)
10. S Nagayama C Fukukawa T Katagiri T Okamoto T Aoyama N Oyaizu, et al. 2005 Therapeutic potential of antibodies against FZD10, a cell-surface protein, for synovial sarcomas Oncogene 24 6201 6212 16007199 10.1038/sj.onc.1208780 1:CAS:528:DC%2BD2MXhtVSjt7nL (Pubitemid 43080043)
11. C Fukukawa H Hanaoka S Nagayama T Tsunoda J Toguchida K Endo, et al. 2008 Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10 Cancer Sci 99 432 440 18271942 10.1111/j.1349-7006.2007.00701.x 1:CAS:528:DC%2BD1MXjs1ygu7w%3D (Pubitemid 351228502)
12. SW Tsai Y Sun LE Williams AA Raubitschek AM Wu JE Shively 2000 Biodistribution and radioimmunotherapy of human breast cancer xenografts with radiometal-labeled DOTA conjugated anti-HER2/neu antibody 4D5 Bioconjug Chem 11 327 334 10821648 10.1021/bc9901292 1:CAS:528:DC%2BD3cXhvVyktrg%3D (Pubitemid 30324898)
13. MA Berger GR Masters J Singleton MS Scully LG Grimm DA Soltis, et al. 2005 Pharmacokinetics, biodistribution, and radioimmunotherapy with monoclonal antibody 776.1 in a murine model of human ovarian cancer Cancer Biother Radiopharm 20 589 602 16398611 10.1089/cbr.2005.20.589 1:CAS:528: DC%2BD28XkvFyqtA%3D%3D (Pubitemid 43099609)
14. XY Zhao D Schneider SL Biroc R Parry B Alicke P Toy, et al. 2005 Targeting tomoregulin for radioimmunotherapy of prostate cancer Cancer Res 65 2846 2853 15805286 10.1158/0008-5472.CAN-04-4019 1:CAS:528:DC%2BD2MXjtVeqtrk%3D (Pubitemid 40490088)
15. 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model J Nucl Med 47 716 725 16595507 1:CAS:528:DC%2BD28Xkt1Oisr0%3D
16. Y Arano Y Fujioka H Akizawa M Ono T Uehara K Wakisaka, et al. 1999 Chemical design of radiolabeled antibody fragments for low renal radioactivity levels Cancer Res 59 128 134 9892197 1:CAS:528:DyaK1MXmsFOmtw%3D%3D
17. G Scatchard 1949 The attraction of proteins for small molecules and ions Ann NY Acad Sci 51 660 672 10.1111/j.1749-6632.1949.tb27297.x 1:CAS:528:DyaH1MXktFGktw%3D%3D
18. B Ng E Kramer L Liebes C Wasserheit H Hochster E Blank, et al. 2001 Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts Cancer Res 61 2996 3001 11306478 1:CAS:528:DC%2BD3MXivFGqs7w%3D
19. DJ Hnatowich F Virzi PW Doherty 1985 DTPA-coupled antibodies labeled with yttrium-90 J Nucl Med 26 503 509 3989606 1:CAS:528:DyaL2MXktlChtbs%3D
20. M Roselli J Schlom OA Gansow A Raubitschek S Mirzadeh MW Brechbiel, et al. 1989 Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenografts J Nucl Med 30 672 682 2785585 1:CAS:528:DyaK3MXhtFOrs78%3D
21. T Saga H Sakahara Y Nakamoto N Sato T Ishimori M Mamede, et al. 2001 Enhancement of the therapeutic outcome of radio-immunotherapy by combination with whole-body mild hyperthermia Eur J Cancer 37 1429 1434 11435076 10.1016/S0959-8049(01)00138-1 1:STN:280:DC%2BD3MznvFSjsA%3D%3D (Pubitemid 32588757)
22. BA Rupnow AD Murtha RM Alarcon AJ Giaccia SJ Knox 1998 Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy Cancer Res 58 1779 1784 9581811 1:CAS:528:DyaK1cXislensLc%3D
23. 90Y-lymphoma therapy Cancer 73 966 973 8306286 10.1002/1097-0142(19940201)73:3+<966::AID-CNCR2820731332>3.0.CO;2-G 1:STN:280:DyaK2c7jvVyrsg%3D%3D
24. C Friesen A Lubatschofski J Kotzerke I Buchmann SN Reske KM Debatin 2003 Beta-irradiation used for systemic radioimmunotherapy induces apoptosis and activates apoptosis pathways in leukaemia cells Eur J Nucl Med Mol Imaging 30 1251 1261 12830326 10.1007/s00259-003-1216-z 1:CAS:528:DC%2BD3sXms12hu78%3D (Pubitemid 37205379)
25. OW Press D Shan J Howell-Clark J Eary FR Appelbaum D Matthews, et al. 1996 Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells Cancer Res 56 2123 2129 8616860 1:CAS:528:DyaK28Xis1ektLY%3D
26. 131I labeled ligands or antibodies Int J Radiat Oncol Biol Phys 46 1025 1036 10705026 1:STN:280:DC%2BD3c7ntFelsQ%3D%3D
27. S Nagayama E Yamada Y Kohno T Aoyama C Fukukawa H Kubo, et al. 2009 Inverse correlation of the up-regulation of FZD10 expression and the activation of beta-catenin in synchronous colorectal tumors Cancer Sci 100 405 412 19134005 10.1111/j.1349-7006.2008.01052.x 1:CAS:528:DC%2BD1MXjt1WrtLw%3D
28. T Kikuchi Y Daigo T Katagiri T Tsunoda K Okada S Kakiuchi, et al. 2003 Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs Oncogene 22 2192 2205 12687021 10.1038/sj.onc.1206288 1:CAS:528:DC%2BD3sXislyitbY%3D (Pubitemid 36539569)